|
|
Volumn 10, Issue 5, 2003, Pages 356-362
|
|
Mass balance study of [14C]M100240, a dual angiotensin-converting enzyme/neutral endopeptidase inhibitor, in healthy male subjects.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
7 (2 ACETYLTHIO 3 PHENYLPROPIONAMIDO) 1,2,3,4,6,7,8,12B OCTAHYDRO 6 OXOPYRIDO[2,1 A][2]BENZAZEPINE 4 CARBOXYLIC ACID;
BENZAZEPINE DERIVATIVE;
CARBON;
DIAGNOSTIC AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
MEMBRANE METALLOENDOPEPTIDASE;
PROTEINASE INHIBITOR;
PYRIDINE DERIVATIVE;
ADULT;
ARTICLE;
CHEMISTRY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG ANTAGONISM;
FECES;
HALF LIFE TIME;
HUMAN;
INTESTINE ABSORPTION;
MALE;
MASS FRAGMENTOGRAPHY;
MIDDLE AGED;
NETHERLANDS;
ORAL DRUG ADMINISTRATION;
REFERENCE VALUE;
TIME;
ADMINISTRATION, ORAL;
ADULT;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BENZAZEPINES;
CARBON RADIOISOTOPES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FECES;
GAS CHROMATOGRAPHY-MASS SPECTROMETRY;
HALF-LIFE;
HUMANS;
INTESTINAL ABSORPTION;
MALE;
MIDDLE AGED;
NEPRILYSIN;
NETHERLANDS;
PROTEASE INHIBITORS;
PYRIDINES;
REFERENCE VALUES;
TIME FACTORS;
|
|
EID: 1542576325
PISSN: 10752765
EISSN: None
Source Type: Journal
DOI: 10.1097/00045391-200309000-00008 Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
